Chemocentryx (CCXI) "ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. The Company targets the chemokine system, a network of molecules, including chemokine ligands and their associated receptors, as well as related chemo-attractant receptors, all of which are known to drive inflammation."
It's been almost two months since my last article on smallcap, ChemoCentryx, posted to Seeking Alpha, and my short term expectations of an immediate CCXI rebound proved inaccurate; to the contrary, the stock suffered another hit, and then gradually declined to the lower 5's. Despite stock performance, I believe the fundamental reasons for long term hope remain valid, and recent indicators support...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|